Clinical Trials Directory

Trials / Completed

CompletedNCT04371471

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

On-admission Multifactorial Evaluation of Inflammation as Prognostic Marker of Death in Patients Diagnosed With Coronavirus Infectious Disease (COVID-19) Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
Groupe Hospitalier de la Rochelle Ré Aunis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

During this pandemic period, the goal of the health care system is to optimize the use of intensive care services for patients infected with SARS-CoV-2, given the frequency of complications that can lead to high mortality. When patients with suspected or confirmed COVID-19 are admitted to hospital, whether or not they are symptomatic, there is currently no method to predict who will progress to complications requiring the use of intensive measures in 24-48 hours.

Detailed description

The body undergoes a systemic adaptation response to severe illness. Elevated cortisol and systemic inflammation are two key responses. Along with hypotension, this triad can lead to end-organ failure and death in critical illness. In critical illness, serum cortisol is dissociated from its tissular activity. We have developed a formula that calculates tissular action of cortisol called the cortisol index. It correlates in chronic ambulatory illness, and acute illness such as myocardial infarction (manuscript pending). Elevated neutrophil to lymphocyte ration (NLR) is a marker of systemic inflammation and predictor of mortality on admission to the emergency department. We have confirmed this in a retrospective and prospective study (manuscript pending, data available upon request). The purpose of this study is to evaluate a triage score (STC-19) based on patients' biological state at the time of diagnosis, to objectively determine which patients are most likely to require intensive medical services within 24-48 hours of presentation of the emergency department.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSTC-19 scoreScore calculated by an algorithm using a vital sign (systolic blood pressure) and biomarkers (complete blood count with differential)

Timeline

Start date
2020-03-01
Primary completion
2020-04-30
Completion
2020-04-30
First posted
2020-05-01
Last updated
2022-07-19
Results posted
2022-04-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04371471. Inclusion in this directory is not an endorsement.